PeptideStack
5.2kquestions
20kanswers
220users

Is 10 mg/mL a sensible working concentration for tirzepatide, or should I go lower?

Asked 12 Jan 2025Modified 15 months agoViewed 16k times
39

Conditions: 10 mg/mL · tirzepatide.

I would like the axes of comparison first and the recommendation second.

I have tried the first option and it works; the question is whether the second is better rather than merely different.

Under what conditions does the answer flip?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
shareeditfollowflag
EH
askedeighty_six_hours20k2712 Jan 2025

5 Answers

Accepted answer first, then by votes
105

Accepted answer

At 10 mg/mL a 0.25 mg draw is 2.5 units on a U-100 barrel and a 2.4 mg draw is 24. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. 2.5 units is too little of the scale to read honestly — half a graduation is 20 per cent of that dose — so going lower in concentration buys resolution you cannot get back after reconstitution. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.

Start from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.

Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.

Concentration and unit conversion at a glance

VialDiluentConcentration0.25 mg0.5 mg1 mg2.5 mg
5 mg1 mL5 mg/mL5 u10 u20 u50 u
5 mg2 mL2.5 mg/mL10 u20 u40 u100 u
10 mg1 mL10 mg/mL2.5 u5 u10 u25 u
10 mg2 mL5 mg/mL5 u10 u20 u50 u
10 mg3 mL3.33 mg/mL7.5 u15 u30 u75 u

Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.

For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.

Nothing here is medical advice, and research-use material is not approved for human use.

Write the concentration on the label at reconstitution, in units per dose.

edited 3 Apr 2025 by orla_ferriter — corrected a unit error in the worked example

shareimprove this answerflag
OF
answered · acceptedorla_ferriter89k14826 Mar 2025
I have seen exactly this failure mode twice and both times it was the diluent volume. – per_haugen 8 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
47

Total vial volume is a physical constraint: most 2 mL vials will not take 3 mL of anything.

The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.

To be exact about it, worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.

U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.

A concentration calculated to three decimal places from a diluent volume measured to one is false precision.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.

shareimprove this answerflag
GA
answeredgrainne_ahearn50k3821 Feb 2025
37

Aim for a dose volume somewhere between about 10 and 30 units on a U-100 barrel and the reading problem disappears.

Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.

Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.

Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.

Concentration equals content over volume, and content is not label claim.

shareimprove this answerflag
TN
answeredtabular_nums71k484 Mar 2025
31

The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.

Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.

The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.

Check the vial can physically hold the volume before you draw it up.

edited 2 May 2025 by felix_araya — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
FA
answeredfelix_araya6.8k1629 Apr 2025
-1

This is the one decision in the whole preparation sequence that cannot be revised later, which is why it is worth thirty seconds of arithmetic.

Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

The general principle here — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science, and it is why licensed presentations contain a surfactant such as polysorbate 20 or 80. A research vial does not, which is precisely why handling matters more, not less.

None of the above is a recommendation to administer anything. Research-use-only material is not approved for human use, and the arithmetic being correct does not make the decision safe.

Measure a volume you can actually measure. Round numbers, real syringes.

shareimprove this answerflag
FR
answeredfib4_reader24k2715 Mar 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.